Redefining Access to Innovative Oncology Therapies: Can Managed Entry Agreements Help?

Abstract

Full Text
Back to November/December 2019
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×